文献速递慢阻肺

常用患者报告结局未能改善慢阻肺急性加重预测:多中心4年半前瞻性队列研究

Commonly Used Patient-Reported Outcomes Do Not Improve Prediction of COPD Exacerbations: A Multicenter 4½ Year Prospective Cohort Study.
PubMed 文献 · Chest · 2017-09-18

结果显示部分PROs与急性加重独立相关,但加入BODEx等指数后预测提升甚微且无临床意义。

要点

  • 部分PROs与急性加重独立相关,但预测增益有限。
  • LAPAQ加入BODEx后AUC仅从0.72升至0.74(Δ+0.02)。
  • 净重分类改善0.03(95%CI -0.03至0.08),无临床意义。

核心结论

  • 部分PROs领域与急性加重独立相关,但加入既有预测指数后未明显改善预测,急性加重预测仍有较大提升空间。

主要发现

  • 呼吸困难、疲乏、焦虑水平较低及体力活动较高与急性加重风险较低相关(校正IRR分别为0.90、0.93、1.03、0.93)。
  • LAPAQ加入BODEx指数时预测最佳,AUC从0.72升至0.74(Δ+0.02)。
  • 净重分类改善为0.03(95%CI -0.03至0.08),该提升无临床相关性。

关键数值与推荐

  • 校正IRR:呼吸困难0.90(95%CI 0.84-0.97,P=.01)、疲乏0.93(95%CI 0.86-1.00,P=.04)、焦虑1.03(95%CI 1.00-1.06,P=.03)、体力活动0.93(95%CI 0.87-0.99,P=.04)。
  • BODEx加LAPAQ的AUC为0.74(Δ+0.02),净重分类改善0.03(95%CI -0.03至0.08)。

临床怎么用

  • 现有PROs可作为了解症状与活动状况的补充,但不宜单独用于预测慢阻肺急性加重。
  • 在BODEx等既有指数基础上常规加入PROs的预测价值有限,需继续探索更好的预测工具。

局限性

  • 原文摘要未系统报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Several cross-sectional and short-term studies suggest that patient-reported outcomes (PROs) may be useful to help predict COPD exacerbations, but evidence from long-term prospective cohort studies is lacking. Our aim was to assess if PROs add to the prediction of exacerbations. METHODS: Four hundred eight primary care patients with COPD participated in the multicenter prospective International Collaborative Effort on Chronic Obstructive Lung Disease: Exacerbation Risk Index Cohorts (ICE COLD ERIC) study. PROs included the Chronic Respiratory Disease Questionnaire, the Hospital Anxiety and Depression Scale, the Feeling Thermometer, and the LASA Physical Activity Questionnaire (LAPAQ). Exacerbations during 4½ years were adjudicated by experts. We used negative binomial regression to assess the association between PROs and exacerbations while considering age, sex, airflow obstruction, previous exacerbations, and smoking status. We then assessed if adding PROs improved the predictive properties of widely used indices. RESULTS: Lower levels of dyspnea, fatigue, and anxiety and higher levels of physical activity were associated with a lower risk of exacerbations (adjusted incidence rate ratio [IRR], 0.90; 95% CI, 0.84-0.97; P = .01; IRR, 0.93; 95% CI, 0.86-1.00; P = .04; IRR, 1.03; 95% CI, 1.00-1.06; P = .03; IRR, 0.93; 95% CI, 0.87-0.99; P = .04, respectively). The best prediction was when LAPAQ was added to the BMI, airflow obstruction, dyspnea, and previous exacerbations (BODEx) index (area under the curve Δ+0.02, from 0.72-0.74). However, this increase was not clinically relevant (net reclassification improvement, 0.03; 95% CI, -0.03 to 0.08). CONCLUSIONS: Some domains of PROs are independently associated with exacerbations but do not lead to clearly improved prediction when added to established indices to predict exacerbations. There is still much room for improvement in the prediction of exacerbations. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT00706602.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Strassmann A, Frei A, Haile SR, et al. Commonly Used Patient-Reported Outcomes Do Not Improve Prediction of COPD Exacerbations: A Multicenter 4½ Year Prospective Cohort Study. Chest. 2017. PMID: 28923760. doi:10.1016/j.chest.2017.09.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。